Home > Specialists > Breast Surgery > Dr. Zhebin Liu (刘哲斌)
Specialty & Clinical Focus:
Associate Chief Physician and breast surgery specialist at Fudan University Shanghai Cancer Center in Shanghai, with a clinical focus on breast cancer surgery, breast-conserving and oncoplastic procedures, implant and latissimus dorsi flap reconstruction, triple-negative and HER2-positive breast cancer, benign breast conditions, and hereditary-risk genetic counseling.
Professional Title & Qualifications:
-
Associate Chief Physician
-
MD, PhD
Hospital & Department：
Fudan University Shanghai Cancer Center – Department of Breast Surgery
(address: No. 270 Dong'an Road, Xuhui District, Shanghai, 200032)
Dr. Zhebin Liu (刘哲斌) - Breast Surgery Specialist
Personal Biography
Dr. Zhebin Liu is an Associate Chief Physician in the Department of Breast Surgery at Fudan University Shanghai Cancer Center (FUSCC), with more than 18 years of clinical experience in oncology and breast surgery. Her practice covers the surgical management of benign and malignant breast tumors, with particular focus on breast-conserving surgery, oncoplastic surgery, sentinel lymph node biopsy, and breast reconstruction using implants or autologous tissue, including the latissimus dorsi flap.
Dr. Liu performs approximately 500 breast cancer surgeries annually and is experienced in individualized treatment planning for triple-negative and HER2-positive breast cancers. She also provides genetic counseling for patients with hereditary breast cancer risks, including risk assessment and fertility-preservation considerations.
She earned her MD and PhD in Oncology from Fudan University, completed postdoctoral training at Houston Methodist Hospital in the United States, and served as a visiting scholar at Queen Mary Hospital in Hong Kong. She was the first recipient from China of the ASCO Long-term International Fellowship (LIFe).
Why Consider Dr. Zhebin Liu for Your Breast Surgery in China?
Dr. Liu combines over 18 years of breast oncology practice at Fudan University Shanghai Cancer Center with international training in the United States and Hong Kong. Her clinical scope spans breast-conserving surgery, oncoplastic procedures, sentinel lymph node biopsy, implant-based reconstruction, and autologous reconstruction using the latissimus dorsi flap. This combination is particularly relevant for international patients who want a specialist opinion that considers both oncological priorities and reconstructive options.
Her experience also includes triple-negative and HER2-positive breast cancers, benign breast conditions, and hereditary-risk genetic counseling. For a focused remote specialist review, patients can prepare pathology reports, imaging, prior treatment records, and a clear list of questions about surgery, reconstruction, hereditary risk, and fertility preservation. This gives Dr. Liu a clearer basis for a case-specific opinion and helps patients prepare more effectively for possible next steps in Shanghai.
Pre-Travel Case Review & Specialist Liaison
Before traveling to Shanghai, MedBridgeNZ coordinates a structured pre-travel specialist-review pathway with Dr. Liu. With your authorization, we help organize and translate relevant pathology reports, imaging, treatment records, and questions, then transfer the prepared file securely to the hospital team and manage appointment communication.
Once the hospital confirms the remote review arrangement, Dr. Liu reviews the submitted records and provides her professional opinion, recommendations, and responses to your questions through the hospital’s specialist-review pathway. The review can clarify surgical or reconstructive options, identify further records or tests needed for the next step, and help you decide whether to pursue an in-person visit. MedBridgeNZ then coordinates translation, administrative follow-up, and travel logistics for a potential visit to Shanghai.
Disclaimer: MedBridgeNZ is a medical concierge provider serving a global client base. We assist with logistical coordination and facilitate access to healthcare professionals. MedBridgeNZ does not provide medical advice, diagnoses, or treatments.Any clinical feedback, treatment planning or suitability discussion remains with the relevant hospital or licensed specialist.
Secure a Remote Case Review with
Dr. Zhebin Liu
Areas of Expertise
Comprehensive Breast Cancer Treatment: Early screening, diagnosis, and multidisciplinary management of breast cancer.
Surgical Oncology: Radical mastectomy, breast-conserving surgery (BCS), and sentinel lymph node biopsy.
Oncoplastic & Reconstructive Surgery: Breast reconstruction using implants and autologous tissue, particularly the latissimus dorsi flap, with attention to cosmetic outcomes and minimizing trauma.
Complex Cases: Individualized treatment for Triple-Negative Breast Cancer (TNBC) and HER2-positive breast cancer, including participation in international clinical trials.
Benign Breast Conditions: Differential diagnosis and management of breast nodules, fibroadenomas, and cysts.
Genetic Counseling: Baylor-CUHK Genetic Counseling program certification for risk assessment and fertility-preservation advice for patients with hereditary breast cancer risks.
Verified Client Satisfaction Metrics
⭐⭐⭐⭐⭐ 5.0/5.0 Overall Rating
* Treatment Pathway Satisfaction:
5.0/5.0
* Communication & Professionalism:
5.0/5.0
* High demand: Chosen online for specialist liaison and case reviews by over:
8,300 clients
(Source: These third-party platform indicators are provided for general reference only. They may change over time and should not be interpreted as a guarantee of diagnosis, treatment suitability, appointment availability, or individual clinical outcome.)
Work Experience
2016.11 – Present: Associate Chief Physician, Department of Breast Surgery, Fudan University Shanghai Cancer Center.
2013.07 – 2016.10: Attending Physician, Department of Breast Surgery, Fudan University Shanghai Cancer Center.
2010.07 – 2013.06: Resident Physician, Department of Breast Surgery, Fudan University Shanghai Cancer Center.
2019.03 – 2019.10: Visiting Scholar, Queen Mary Hospital, Hong Kong.
2013.02 – 2014.10: Postdoctoral Fellow, Houston Methodist Hospital, USA.
Education & Training
PhD in Oncology: Fudan University Shanghai Cancer Center.
MD / Master’s Degree: Fudan University (Clinical Medicine 7-year program).
Postdoctoral Training: Houston Methodist Hospital, USA.
Awards & Honors
ASCO Long-term International Fellowship (LIFe) (sole recipient from China).
AACR International Scholar-in-Training Grant.
St. Gallen International Breast Cancer Conference Travel Grant.
San Antonio Breast Cancer Conference Travel Grant.
Shanghai Medical Science and Technology Award (3rd Prize).
Shanghai “Technology Entrepreneurship Cup” Innovation Award (3rd Prize).
Outstanding Graduate of Shanghai.
Academic & Professional Memberships
Expert Group Member, Chinese Anti-Cancer Association (CACA) Breast Cancer Committee Guidelines Tour.
Consultation Expert for Shanghai Medical Alliance and various national medical associations.
Speaker and Commentator at various professional academic conferences.
Research & Publications
Publications: Published over 20 academic papers as first or corresponding author in professional journals.
Grants: Led one National Natural Science Foundation project, two Shanghai Natural Science Foundation projects, and multiple university-level grants.
Patents: Holds one national patent.
Book Contributions: Participated in the compilation and translation of authoritative medical texts such as “Breast Oncology” and “Ductal Carcinoma In Situ”.
Mentorship: Currently supervising multiple Master’s and PhD students.
Selected Peer-Reviewed Publications
Selected peer-reviewed publications involving Dr. Liu:
Liu ZB et al. Detection of breast cancer stem cell gene mutations in circulating free DNA during the evolution of metastases. Breast Cancer Res Treat. 2019;178(2):251–261. PMID: 31388936
Qu FL, Liu ZB, et al. Omission of axillary surgery for ipsilateral breast tumor recurrence with negative nodes after previous breast-conserving surgery: is it oncologically safe? Breast Cancer Res Treat. 2022;196(1):97–109. PMID: 36040640
Qu FL, Liu ZB, et al. Spatiotemporal Patterns of Loco-Regional Recurrence After Breast-Conserving Surgery. Front Oncol. 2021;11:690658. PMID: 34527574
*The doctor’s information is sourced from the hospital’s official website or provided directly by the doctor. Due to update cycles, there may be occasional delays in reflecting the most recent changes.
Frequently Asked Questions (FAQs)
Can Dr. Zhebin Liu review my breast cancer diagnosis and surgical options before I travel?
Dr. Liu’s clinical scope includes breast-conserving surgery, oncoplastic surgery, implant and autologous reconstruction, triple-negative and HER2-positive breast cancer, benign breast conditions, and hereditary-risk genetic counseling. MedBridgeNZ can coordinate a remote specialist-review request using your pathology reports, imaging, treatment history, and questions. Once the hospital confirms the arrangement, Dr. Liu reviews the submitted records and provides her professional opinion, recommendations, and responses to your questions. This can help you understand which surgical or reconstructive topics should be discussed before deciding whether to travel to Shanghai.
What records should I prepare for a remote specialist review with Dr. Liu?
Useful records typically include pathology reports, breast imaging, previous operation notes, prior treatment summaries, current medical reports, and a concise list of questions. MedBridgeNZ helps organize the file, coordinate English–Chinese translation where required, and transfer the documents with your authorization to the hospital team. A complete, clearly structured record set gives Dr. Liu the information needed to review the case efficiently and respond to questions about breast-conserving surgery, mastectomy, reconstruction, hereditary risk, or other relevant next steps.
How does MedBridgeNZ coordinate a medical trip to Shanghai if I decide to proceed?
After the specialist-review pathway and proposed next steps are clear, MedBridgeNZ can assist with appointment request coordination, hospital communication, medical invitation or visa-document coordination support, travel planning, accommodation arrangements, translation coordination, and non-clinical bilingual administrative support during hospital visits. We also help keep your itinerary, records, and appointment information organized before departure. Hospital appointment timing and clinical arrangements are confirmed by the relevant hospital or specialist team, while MedBridgeNZ manages the administrative and logistical work around the visit.
Flexible Ways to Connect with the Specialist
We understand that every client’s situation is unique. Beyond the Remote Written Review, we offer a range of flexible ways to access specialist insights:
-
Remote Video Liaison: For a more personal interaction, we can arrange a live video session, allowing you to discuss your case directly with the specialist with the help of our professional medical translators.
-
On-Site Proxy Liaison: If you cannot travel, our dedicated bilingual team can visit the hospital in person on your behalf. We will present your translated medical records to the specialist, facilitate your inquiries, and provide you with a comprehensive translated report of the doctor’s findings.
-
In-Person Appointment Booking: If you are planning to travel to China for treatment, we manage the complex hospital registration and appointment process, ensuring you have confirmed access to your chosen specialist upon arrival.
How MedBridgeNZ Helps You:
MedBridgeNZ is a medical concierge and logistics coordination provider for international patients exploring specialist-care pathways in China. We assist with appointment request coordination, medical-record preparation, translation coordination, client-authorized document transfer, medical invitation or visa-document coordination support, travel planning, and non-clinical bilingual administrative assistance in Shanghai. MedBridgeNZ does not provide medical advice, diagnosis, or treatment. Hospital, specialist, diagnostic, treatment, medication, travel, and accommodation charges are third-party costs and remain separate from MedBridgeNZ coordination fees unless expressly confirmed otherwise in writing.